Group 1 - The Hong Kong IPO market experienced a collective downturn on December 22, 2025, with four newly listed stocks, including Impression Da Hong Pao (HK02695), Huaren Biotech-B (HK02396), Ming Kee Hospital (HK02581), and Nanhua Futures (HK02691), all facing significant declines, with Ming Kee Hospital dropping 49.46%, marking the worst debut performance of the year [1] - All four new stocks opened lower and continued to decline throughout the trading day, closing near their lowest prices. Ming Kee Hospital, which had an offering price of 9.34 HKD, closed at 4.73 HKD, resulting in a loss of 1,420 HKD per lot of 500 shares, surpassing the previous record decline of 47.67% set by Conch Cement Technology [1] - Impression Da Hong Pao, despite receiving a 3,400 times oversubscription and a pre-listing increase of 11% on the Futu platform, ultimately closed down 35.28% at 2.33 HKD, leading to a loss of 1,270 HKD per lot of 1,000 shares [1] Group 2 - Following the reform of the Hong Kong IPO pricing mechanism in August 2025, the new stock failure rate was only 7.14% from August to October, but it surged to 42.10% from November onwards, significantly exceeding the 30.23% rate observed in the first half of the year [2] - The core reason for this discrepancy is the misalignment between primary market pricing and secondary market risk appetite, with issuers often referencing A-share valuations while Hong Kong investors prioritize cash flow and dividend returns, compounded by increased pressure from southbound capital and smaller float sizes, leading to concentrated sell-offs post-listing [2] - The Hong Kong IPO market has reached a scale of 267.1 billion HKD this year, with potential to reclaim the top position globally for IPOs. However, ongoing fluctuations in Federal Reserve policy expectations and changes in cross-border capital flows indicate that the valuation restructuring in the Hong Kong new stock market is still ongoing, resulting in a more cautious sentiment among investors regarding new listings [2]

Group 1: Impact of Hong Kong IPOs on Secondary Market - The Hong Kong IPO market has significantly rebounded this year, with approximately 100 companies raising over 250 billion HKD, and the expected IPO financing center for 2026 is around 330 billion HKD [1] - There is a positive correlation between IPO financing in the primary market and the performance of the Hang Seng Index, suggesting a mutual causation [2] - A weak US dollar and low Hibor rates are common factors driving the simultaneous strength of both IPO and secondary markets, as investors tend to reduce US asset allocations and increase global market allocations, with Hong Kong stocks being a potential option [3] Group 2: Performance of Secondary Market Post-IPO - Large IPOs do not have a significant overall impact on the secondary market, as the Hang Seng Index shows no clear pattern in the 20 trading days prior to large IPOs, while the probability of the index strengthening in the 20 trading days following a large IPO is 56%, with a median increase of 4% [4] - The probability of large IPOs being successful is high, with positive median absolute and excess returns from listing to the time of inclusion [5] Group 3: New Consumption Policies - Recent policies from the Ministry of Commerce and the Ministry of Finance aim to promote new consumption formats, with pilot programs launched in 50 cities, emphasizing the need for robust implementation plans and project management [6] - The younger generations, particularly Y and Z, are becoming the main consumer force, with a focus on personalized and emotional consumption, leading to the rise of industries like the "guzi economy" [6] - The new consumption sector is expected to evolve towards three trends (health, new pragmatism, and emotional consumption) and two dimensions (intelligent and overseas consumption), suggesting investment opportunities in these areas [6]

记者 牛钰 年末临近，持续一年的港股IPO（首次公开发行）热潮持续。12月18日，一日之内六家港股拟IPO企业启动招股，并均计划于2025年12月30日正式挂牌上 市，港股将以"六锣齐响"为其成为今年全球第一IPO市场庆贺。 12月18日，德勤在《中国内地及香港IPO市场2025年回顾与2026年前景展望》中称，港交所第四季度继续迎来两只超大型新股上市，全年维持环球新股融资 额榜首宝座，纳斯达克位列第二，印度国家证券交易所凭借更多新股超越纽交所跻身三甲，上交所和深交所排名第五和第八。 图片来源：德勤中国资本市场服务部 德勤中国资本市场服务部上市业务华北及华西区主管合伙人任绍文表示，香港在2025年取得辉煌的成绩，再次夺回了全球新股市场的桂冠。 "今年新股融资总额在第二季度大幅反弹，但尚未能突破2020年、2021年的高位，当时两年的新股融资总额均超过3300亿港元。"任邵文称，展望2026年，香 港新股市场有望再创融资额的纪录，至少达到3000亿港元。 德勤中国资本市场服务部预计，2025年香港将完成114只新股，同比增长63%；合计上市融资约2863亿港元，同比增长逾两倍。其中，19项A+H股上市项目 的融 ...

Core Viewpoint - The Hong Kong stock market is entering a significant phase for annual IPOs, with six companies launching their offerings and scheduled to list on December 30, reflecting a strong demand for quality enterprises to utilize market opportunities [1][2]. Group 1: Companies and Their Offerings - Six companies, including Insilico Medicine, Wuyishijie, Xunce, Meilian Holdings, Woan Robotics, and Linqingxuan, are set to launch IPOs, covering diverse sectors such as AI pharmaceuticals, digital twins, home robotics, and high-end skincare [1][2]. - Insilico Medicine, known as a pioneer in AI pharmaceuticals, has set its IPO price at HKD 24.05, aiming to raise HKD 2.277 billion, making it the largest among the six [1]. - Wuyishijie, focusing on digital twin and Physical AI technologies, plans to issue 23.975 million shares at HKD 30.5 each, with a potential fundraising of up to HKD 841 million if the over-allotment option is exercised [2]. - Xunce, a real-time data infrastructure service provider, is expected to raise between HKD 1.08 billion and HKD 1.23 billion, with a share price range of HKD 48-55 [2]. - Woan Robotics, backed by industry figure Li Zexiang, is entering the home robotics sector, while Linqingxuan is offering 13.96645 million shares at HKD 77.77 each [2]. Group 2: Market Trends and Analysis - The concentration of tech and new consumer companies in the IPO market indicates a shift in the structure of IPOs, with technology and new consumption becoming the dominant forces [1][3]. - The traditional industrial sector, represented by Meilian Holdings, highlights the financing needs of transforming traditional industries, aligning with the "technology-led, diversified supplement" structure of the Hong Kong IPO market [3]. - The influx of new IPOs may lead to market differentiation, where the quality of cornerstone investors and the ability to deliver on performance will be critical in distinguishing the companies [3]. - The simultaneous issuance of multiple new stocks may create a fund diversion effect, impacting the demand for public offerings and international placements [3].

Group 1: A-Share Market Outlook - The A-share market is expected to see 114 companies listed by December 31, 2025, raising approximately 129.6 billion yuan, representing a 14% increase in new listings and a 94% increase in total financing compared to 2024 [1] - The ChiNext board is projected to have the highest number of new listings (19), while the Shanghai Stock Exchange is expected to lead in financing amount (43.2 billion yuan) [1] - The Shanghai Stock Exchange is anticipated to maintain its position as the fifth largest stock exchange globally, with a new stock financing amount of 80 billion yuan [1] Group 2: Hong Kong IPO Market Forecast - Hong Kong is projected to complete 114 new stock listings in 2025, raising around 286.3 billion HKD, which indicates a 63% increase in new listings and more than a twofold increase in financing compared to the previous year [2] - The positive outlook for Hong Kong's IPO market is attributed to various reforms, including simplified listing approval processes and the establishment of a special listing system for technology companies [2] - In 2026, approximately 160 new stocks are expected to be listed in Hong Kong, with total financing of at least 300 billion HKD, including seven stocks each raising at least 10 billion HKD [2] Group 3: U.S. Market for Chinese Companies - About 63 Chinese companies are expected to list in the U.S. in 2025, raising approximately 1.12 billion USD, which is a 7% increase in the number of new listings but a 41% decrease in financing compared to 2024 [3] - The largest two Chinese companies listed in the U.S. this year are from the consumer and pharmaceutical sectors [3] - There is a cautious outlook for Chinese companies listing in the U.S. in 2026, particularly if proposed listing thresholds by Nasdaq are approved, which may lead to a decrease in the number of eligible Chinese companies [3]

Core Insights - Deloitte's report indicates a steady growth in the number of IPOs and financing amounts in the A-share market for 2026, with an expected 114 companies going public and raising 129.6 billion yuan [1] - The Hong Kong IPO market is projected to see around 160 new listings in 2026, with total financing expected to exceed 300 billion HKD [2] A-Share Market Summary - In 2025, the A-share market is expected to have 114 new listings, raising a total of 129.6 billion yuan, which represents a 14% increase in the number of IPOs and a 94% increase in financing compared to 2024 [1] - The top five IPOs in 2025 are projected to raise a total of 39.4 billion yuan, a significant increase of 260% from the previous year's 10.9 billion yuan [1] - Companies in priority sectors such as AI, new energy, high-end manufacturing, commercial aerospace, quantum technology, and biomanufacturing are expected to have a competitive advantage in the A-share market [1] Hong Kong Market Summary - For 2025, Hong Kong is anticipated to have 114 new IPOs, raising approximately 286.3 billion HKD, marking a 63% increase in the number of IPOs and a 227% increase in financing compared to the previous year [1] - The Hong Kong Stock Exchange is expected to lead global exchanges in total IPO financing for 2025 [1] - In 2026, the Hong Kong market is projected to have around 160 new listings, with at least 7 of them expected to raise over 10 billion HKD each, including leading mainland enterprises [2] - The focus will also be on "A+H" stock applicants, as well as sectors like technology, media, telecommunications, healthcare, consumer goods, and international companies [2]

2025年的全球资本市场舞台中央，香港再度成为最耀眼的聚光灯焦点，多项数据创下了历史新高。总体 来看，今年香港新股市场已迎来超过100家新上市公司，其中不仅包含年内全球规模最大的两宗IPO， 融资总额更是突破2700亿港元，在集资额上稳居全球首位。 其中，"A+H"上市模式成为强劲引擎，上市数量在2025年创下历史新高。募资总额超1360亿港元，占据 全部募资总额的半壁江山，与2024年相比更是增加超220%。同时，"A+H"的上市速度也在不断提升， 平均上市时间为4至6个月，其中最快的一宗仅用了约3个月。尤其引人注意的是，港交所目前正在处理 的上市申请已超过310宗，也创下历史新高。 这份亮丽的成绩单，标志着香港IPO市场已经从复苏走向了强劲增长，业内多家机构给出了积极的展 望。 华泰证券分析认为，2026年港股市场的IPO融资可能仍将较为活跃。首先是当前港股已递表处理中的上 市申请已超310家，项目储备丰富。其次从年度维度看，通常前一年二级市场的表现会影响上市公司的 递表决策。今年年初以来，恒生综指整体表现亮眼，涨幅超30%，同样指引明年港股主板的IPO融资热 度有望维持高位。 最后是扩大上市公司来源。她 ...

2025年港股IPO市场迎来爆发式增长，募资规模登顶全球主要交易所的同时，上市排队企业数量也持续攀升，形成一定程度的"堰塞湖"现象。 最新数据统计显示，截至12月17日，处于港股IPO聆讯处理中阶段的企业多达298家，其中12月半个多月内新增28家，远超11月同期的 18家，排队企业增速明显，后续节奏变化备受市场关注。此外，从市场格局来看，年内港股IPO已完成102家上市，募资额达2724.76亿 港元，同比激增226.62%，创下四年以来新高。 港股IPO"堰塞湖"现象背后，是市场对热度与潜在风险的担忧，港股监管层已针对申报质量下滑发出联合关切，投行人手短缺、文件粗糙等问题引 发关注；而二级市场"抽血"担忧虽持续发酵，但卖方研究显示一二级市场弱正相关，短期压力难改长期产业赋能逻辑，港股在规模扩张与风险防控 的平衡中持续前行。 近300家企业排队港股IPO Wind数据统计显示，科技与创新驱动的行业主导上述拟上市项目中，软件服务与硬件设备占比最高，合计约35%；医药生物行业多达6 家企业，聚焦创新药、肿瘤治疗、自身免疫疾病等高壁垒赛道，政策支持与市场需求双重驱动。 消费者服务与日常消费零售占比约25%，传统消 ...

深圳商报·读创客户端记者 詹钰叶 首次递表后，因股权架构、分红合理性、社保欠缴等问题，巴奴国际控股有限公司（简称巴奴火锅）被中国证监会"九连问"。公司于12月17日向港交所二次 递表，并作出针对性解释。若顺利上市，巴奴火锅将成为港股"中式火锅第三股"。 图片内容均来自巴奴火锅本次递交的招股书 12月17日，巴奴国际控股有限公司（以下简称"巴奴火锅"或"公司"）更新招股书，中金公司、中银国际为联席保荐人。根据招股书，巴奴火锅成立于2001年 4月，总部位于河南省郑州市，创始人为杜中兵。弗若斯特沙利文数据显示，按收入计，巴奴火锅在2024年中国火锅市场中的排名位于海底捞、呷哺呷哺之 后，位列第三，市场份额约为0.4%；在中国高端火锅市场则排名第一，市场份额约为3.1%。 招股书显示，至12月7日，巴奴火锅的直营门店达162家，覆盖46个城市，较2021年末增长95.2%，"河南模式"成功复制至全国多省份。2022年-2025年前九个 月，公司营业收入分别为14.33亿元、21.12亿元、23.07亿元与20.7亿元，净利润分别为-0.05亿元、1.02亿元、1.23亿元与1.56亿元，毛利率分别为66.2%、 6 ...

Group 1: IPO Information - The IPO for 英矽智能 (03696.HK) is open for subscription from December 18 to December 23, with a global offering of 94,690,500 shares, where 10% is for public offering in Hong Kong and 90% for international offering. The offer price is set at HKD 24.05 per share, with a minimum investment of HKD 12,146.27 for 500 shares [2][4] - The IPO for 五一视界 (06651.HK) is also open for subscription from December 18 to December 23, with a global offering of 23,975,200 shares, where 5% is for public offering in Hong Kong and 95% for international offering. The offer price is set at HKD 30.50 per share, with a minimum investment of HKD 6,161.51 for 200 shares [8][10] - 迅策 (03317.HK) is offering 22,500,000 shares from December 18 to December 23, with 10% for public offering in Hong Kong and 90% for international offering. The price range is HKD 48.00 to HKD 55.00 per share, with a minimum investment of HKD 5,555.47 for 100 shares [13][15] - 美联股份 (02671.HK) is offering 24,600,000 shares from December 18 to December 23, with 10% for public offering in Hong Kong and 90% for international offering. The price range is HKD 7.10 to HKD 9.16 per share, with a minimum investment of HKD 2,775.71 for 300 shares [19][21] - 卧安机器人 (06600.HK) is offering 22,222,300 shares from December 18 to December 23, with 10% for public offering in Hong Kong and 90% for international offering. The price range is HKD 63.00 to HKD 81.00 per share, with a minimum investment of HKD 8,181.69 for 100 shares [25][27] - 林清轩 (02657.HK) is offering 13,966,500 shares from December 18 to December 23, with 10% for public offering in Hong Kong and 90% for international offering. The offer price is set at HKD 77.77 per share, with a minimum investment of HKD 3,927.72 for 50 shares [30][32] Group 2: Financial Performance - 英矽智能 reported revenues of USD 30.15 million, USD 51.18 million, USD 85.83 million, USD 59.69 million, and USD 27.46 million for the years 2022, 2023, 2024, and the six months ending June 30, 2025, respectively. The net losses for the same periods were USD 221.83 million, USD 211.64 million, USD 17.10 million, USD 8.03 million, and USD 19.22 million [7] - 五一视界's revenue grew from RMB 169.98 million in 2022 to RMB 256.30 million in 2023, and further to RMB 287.36 million in 2024. The revenue for the six months ending June 30, 2025, was RMB 53.82 million, showing a 62.0% increase from the same period in 2024. The net losses for the same periods were RMB 189.79 million, RMB 87.08 million, RMB 78.97 million, RMB 65.07 million, and RMB 94.05 million [12][12] - 迅策's revenue for the years 2022, 2023, and 2024 was RMB 288 million, RMB 530 million, and RMB 632 million, respectively, with net losses of RMB 97 million, RMB 63 million, and RMB 98 million for the same years [18] - 美联股份 reported revenues of RMB 1,902.84 million, RMB 1,453.18 million, RMB 1,523.03 million, RMB 509.51 million, and RMB 1,424.11 million for the years 2022, 2023, 2024, and the six months ending June 30, 2025, respectively. The net profits for the same periods were RMB 87.71 million, RMB 62.13 million, RMB 70.78 million, RMB 13.61 million, and RMB 62.63 million [23] - 卧安机器人的 revenue for the years 2022, 2023, and 2024 was RMB 274.60 million, RMB 457.26 million, and RMB 609.92 million, respectively, with net losses of RMB 86.98 million, RMB 16.38 million, and RMB 3.07 million. The company reported a net profit of RMB 27.90 million for the six months ending June 30, 2025 [29][29] - 林清轩's total revenue for the years 2022, 2023, 2024, and the six months ending June 30, 2025, was RMB 691.15 million, RMB 805.00 million, RMB 1,209.64 million, RMB 530.45 million, and RMB 1,051.77 million, respectively. The company transitioned from a net loss of RMB 5.93 million in 2022 to a net profit of RMB 84.52 million in 2023 and further increased to RMB 186.83 million in 2024 [34]